Aimed Alliance Releases 2020 Annual Report
In 2020, Aimed Alliance engaged in a wide array of activities to protect and enhance…
In 2020, Aimed Alliance engaged in a wide array of activities to protect and enhance…
On March 9, 2020, the U.S. Food and Drug Administration (FDA) and the Federal Trade…
On March 30, 2020, Aimed Alliance published a position statement on products containing cannabidiol (CBD).…
On March 6, 2020, the National Psoriasis Foundation delivered a sign-on letter to the House…
On March 11, 2020, Aimed Alliance joined a coalition of patient advocacy groups and provider…
On March 9, 2020, Aimed Alliance sent a sign-on letter to HealthPartners, which is a…
On March 4, 2020, Kentucky HB 72, a bill that would limit the use of…
On January 31, 2020, the Centers for Medicare & Medicaid Services (CMS) released the proposed…
Aimed Alliance experienced significant growth in 2019, and we are excited to share our progress…
On January 27, 2020, Oregon legislators introduced HB 4114, which would set physician payment rates…